[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578068":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":37,"collaborators":7,"id":39,"slug":7,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Pier Luigi Zinzani, MD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+39 0512143680","pierluigi.zinzani@unibo.it",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},"Alessandro Broccoli, MD","Alessandro.broccoli@studio.unibo.it",[21],{"facility":22,"status":23,"city":24,"state":24,"zip":25,"country":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"IRCCS Azienda Ospedaliero - Universitaria di Bologna","RECRUITING","Bologna","40138","Italy",{"type":28,"coordinates":29},"Point",[30,31],11.33875,44.49381,{"lat":31,"lon":30},[34,36],{"name":10,"role":14,"phone":35,"phoneExt":7,"email":16},"+390512143680",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100578068",false,"NCT06806488","Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas","Retrospective Observational Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas","MarZoLyOss","Inclusion Criteria:\n\n1. Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.\n2. Age ≥ 18 years at enrolment.\n3. Written informed consent (if applicable)\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":49,"type":50},160,"ESTIMATED","OBSERVATIONAL","This is a purely retrospective and observational monocentric study",[54],"Marginal Zone B Cell Lymphoma","2025-01-28",{"date":57,"type":58},"2025-02-04","ACTUAL",{"date":60,"type":50},"2025-05",{"date":62,"type":50},"2025-10",{"name":5,"class":6},1]